The risk factors of cardiovascular disorders in children with chronic bronchopulmonary diseases
DOI:
https://doi.org/10.14739/2310-1210.2018.02.125170Keywords:
pulmonary disease, cystic fibrosis, asthma, child, cardiovascular systemAbstract
The purpose was to determine the features of cardiovascular system morphofunctional state and the risk factors for cardiovascular disorders formation in children with chronic bronchopulmonary diseases.
Materials and methods. We examined 144 patients aged 3–16 years (mean age was 11.3 ± 1.2 years) with chronic bronchopulmonary pathology (60 patients with cystic fibrosis with pancreatic insufficiency and 84 patients with heavily treated or partially treated persistent bronchial asthma) and 68 conditionally healthy children who made up the control group. A complex of functional methods for cardiovascular system studying in patients with chronic bronchopulmonary diseases included: echodopplercardiography with determination of left ventricular myocardium geometry, Holter monitoring of cardiac activity, duplex scanning of the common carotid artery by intima-media thickness measuring of the common carotid artery wall and examining the index of endothelial stress shift. To determine the risk factors for cardiovascular disorders development in children with chronic bronchopulmonary diseases, a method E. N. Shigan was used to normalize intensive indicators, based on the Bayesian probabilistic method. A prognostic model of cardiovascular disorders development was obtained using the exponential regression equation for patients with chronic bronchopulmonary diseases.
Results. According to results of the study it has been found that there is a structural and functional restructuring of the left ventricular myocardium on the background of the cardiac activity vegetative regulation violation and vascular remodeling in children with chronic bronchopulmonary diseases. The definition of risk factors for cardiovascular complications development in children with bronchial asthma has showed the followings: the presence of chronic infection (OR = 8.4), the age of child from 3 to 6 years (OR = 4.9), the disease duration more than 3 years (OR = 2.3), the circadian index value less than 1,2 units (OR = 3.1) and QTc interval prolongation more than 420 ms (OR = 2.1). The main risk factors for cardiovascular disorders formation in the group of children with cystic fibrosis were the age of the child from 3 to 6 years (OR = 4.0), contamination of the respiratory tract by Pseudomonas aeruginosa (OR = 4.0), severe course of the disease (OR = 3.3), the presence of chronic infection (OR = 6.0), the body mass index less than P50 (OR = 4.2) and the QTc interval duration more than 420 ms (OR = 1.4). The risk of cardiovascular complications was increased with the presence of 3 or more risk factors that confirmed by the equation of exponential regression in the group of patients with chronic bronchopulmonary diseases.
Conclusions. The development of cardiovascular complications is caused by a combination of many factors in children with chronic bronchopulmonary diseases. It is necessary to include into the algorithm for examination heart echodopplerography, Holter heart rate monitoring, duplex scanning of the common carotid artery with determination of the endothelial stress index shift and intima-media thickness at least twice a year for the purpose of cardiovascular disorders early diagnosis in children with chronic bronchopulmonary diseases, having 3 or more risk factors for cardiovascular complications. Timely detection of a risk group for cardiovascular disorders development will allow the full implementation of preventive measures and medications for cardiovascular disorders correcting in children with chronic bronchopulmonary diseases.
References
Babtseva, A. F., Romantsova, E. B., & Prikhodko, O. B. (2015). Prevalence of chronic respiratory diseases among children in blagoveshchensk 10 years. Amurskij medicinskij zhurnal, 2(10), 8–10.
Nedelskaya, S. N. & Yartseva, D. A. (2013). Diagnostika bronhial'noj astmy u detej rannego vozrasta: vozmozhnosti, problemnye voprosy, differencial'naya diagnostika [Diagnostics of Bronchial Asthma in Infants: Possibilities, Topical Issues, Differential Diagnosis]. Zdorov'e rebenka, 2(45), 108–111 [in Russian].
Malysh, E. Yu., Drobysheva, E. S., & Chernov, A. V. (2014). Khronicheskaya obstruktivnaya bolezn' legkikh i porazhenie serdechno-sosudistoj sistemy [The chronic obstructive pulmonary disease and cardiovascular disease]. Molodoj uchenyj, 5(64), 145–148. [in Russian].
Cazzola, M., Calzetta, L., Bettoncelli, G., Novelli, L., Cricelli, C., & Rogliani, P. (2011). Asthma and comorbid medical illness. Europ. Resp. J., 38(1), 42–49. doi: 10.1183/09031936.00140310.
Bushueva, E'. V., Sokolova, I. S., & Gerasimova, L. I. (2015). Sostoyanie serdechno-sosudistoj sistemy u bol'nykh s bronkhial'noj astmoj [The state of the cardiovascular system in patients with bronchial asthma]. Sovremennye problemy nauki i obrazovaniya, 3. Retrieved from http://science-education.ru/ru/article/view?id=19454 [in Russian].
Kathiresan, S., & Srivastava, D. (2012). Genetics of human cardiovascular disease. Cell, 148(6), 1242–1257. doi: 10.1016/j.cell.2012.03.001.
Gonchar' M. A., Cyura, O. N., Omel'chenko, E. V., Muratov, G. R., & Bashkirova, N. V. (2017) Faktory riska razvitiya patologii serdechno-sosudistoj sistemy u detej s bronholegochnoj patologiej [The risk factors for the development of cardiovascular pathology in children with bronchopulmonary pathology] Aktual'nye problemy mediciny. Proceedings of the Republican Scientific and Practical Conference and the 26th summary scientific session of the Gomel State Medical University. (P. 193–195). Gomel. [in Russian].
Nakaz MOZ Ukrainy «Unifikovanyi klinichnyi protokol pervynnoi, vtorynnoi (spetsializovanoi) medychnoi dopomogy. Bronkhial'na astma u ditej» vid 08 zhovtnia 2013 roku №868 [The order of the Ministry of Health of Ukraine «Unified clinical protocol of primary, secondary (specialized) medical aid. Bronchial asthma in children» from October 08, 2013 №868]. [in Ukrainian].
Nakaz MOZ Ukrainy «Pro zatverdzhennia klinichnykh protokoliv nadannia medychnoi dopomohy za spetsialnistiu «Pulmonolohiia» Protokol nadannia medychnoi dopomohy khvorym na mukovistsydoz» vid 19 bereznia 2007 roku №128 [The order of the Ministry of Health of Ukraine «On Approval of Clinical Protocols for the Provision of Medical Aid on the Specialty «Pulmonology» Protocol on the Provision of Medical Aid to Cystic fibrosis Disease Patients» from March 19, 2007, №128]. [in Ukrainian].
Daniels, S. R., Kimball, T. R., Morrison, J. A., Khoury, P., & Meyer, R. A. (1995). Indexing left ventricular mass to account for differences in body size in children and adolescents without cardiovascular disease. Am. J. Cardiol, 76, 699–701.
Rozenbaum, A. N., & Koval, V. T. (patentee) (2011) Patent 2425631 Rossijskaya Federaciya, MPK A61B8/00. Sposob rannej diagnostiki sostoyaniya miokarda. – №2009100504/14 [Pat. 2425631 Russian Federation, IPC A61B8/00. A method for early diagnosis of the myocardium state №2009100504/14]. Byuleten', 20. [in Russia].
Pignoli, P., Tremoli, E., Poli, A., Oreste, P., & Paoletti, R. (1986). Intima plus media thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation, 74, 1399–1406. doi: 10.1161/01.CIR.74.6.1399.
Karpov, Yu. A., Ivanova, O. V., Rogoza, A. N., At'kov, O. Yu., Soboleva, G. N., & Balakhonova, T. V. (1998). Opredelenie chuvstvitel'nosti plechevoj arterii k napryazheniyu sdviga na e'ndotelij kak metod ocenki sostoyaniya e'ndotelijzavisimoj vazodilatacii s pomosch'yu ul'trazvuka vysokogo razresheniya u bol'nykh s arterial'noj gipertenziej [The determination of the sensitivity of the brachial artery to the shear stress on the endothelium as a method of assessing the state of endothelium-dependent vasodilation using ultrasound of high resolution in patients with arterial hypertension]. Kardiologiya, 3, 37–41. [in Russian].
Rabochaya gruppa Evropejskogo kardiologicheskogo obschestva i Severo-Amerikanskogo obschestva stimulyacii i e'lektrofiziologii (1999) Variabel'nost' serdechnogo ritma. Standarty izmereniya, fiziologicheskoj interpretacii i klinicheskogo ispol'zovaniya [The heart rate variability. Standards of measurement, physiological interpretation and clinical use]. Vestnik aritmologii, 11, 53–78. [in Russian].
Shigan, E. N. (1986). Metody prognozirovaniya i modelirovaniya v social'no-gigienicheskikh issledovaniyakh [The methods of forecasting and modeling in social and hygienic research]. Moscow: Medicina. [in Russian].
Udelson, J. E., & Konstam, M. A. (2011). Ventricular RemodelingFundamental to the Progression (and Regression) of Heart Failure. J. of the American College of Cardiol, 57(13), 1477–1479. doi: 10.1016/j.jacc.2011.01.009.
Baevskij, R. M., Ivanov, G. G., Chirejkin, L. V., Gavrilushkin, A. P., Dovgalevskij, P. Ya., Kukushkin, Yu. A., et al. (2001). Analiz variabel'nosti serdechnogo ritma pri ispol'zovanii razlichnykh e'lektrokardiograficheskikh sistem [The analysis of heart rate variability when using various electrocardiographic systems]. Vestnik aritmologii, 24, 66–85. [ in Russian].
Abdalla, M. E., & Abd El Azeem, H. (2013). Echocardiographic evaluation of ventricular function in young adults with bronchial asthma. Egyp. J. of Chest Diseases and Tuberculosis, 62(1), 27–31. doi: https://doi.org/10.1016/j.ejcdt.2013.04.001.
Cohn, J. N. (1995). Critical review of heart failure: the role of left ventricular remodeling in the therapeutic response. Сlin. Cardiol, 18 (IV), 4–12. doi: 10.1002/clc.4960181603.
Nechesova, T. A., Korobko, I. Yu., & Kuznecova, N. I. (2008). Remodelirovanie levogo zheludochka: patogenez i metody ocenki [Left ventricular remodeling: pathogenesis and evaluation methods]. Medicinskie novosti, 11, 7–13.[ in Russian].
Guazzi, M., Phillips, S. A., Arena, R., & Lavie, C. J. (2015). Endothelial dysfunction and lung capillary injury in cardiovascular diseases. Progress in cardiovascular diseases, 57(5), 454-462. doi: 10.1016/j.pcad.2014.11.003.
Glezeva, N., & Baugh, J. A. (2014). Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target. Heart failure reviews, 19(5), 681–694. doi: 10.1007/s10741-013-9405-8.
Lezhenko, H. O., & Pashkova, O. Ye. (2013). Stan funktsii endoteliiu u ditei z khronichnymy ta retsydyvnymy zakhvoriuvanniamy bronkholehenevoi systemy [The state of the endothelial function in children with chronic and recurrent bronchopulmonary diseases of the bronchopulmonary system]. Bukovynskyi medychnyiy visnyk, 17, 3(2), 48–52. [in Ukrainian].
Lezhenko, G., & Pashkova, E. (2013). Rol' vospaleniya v razvitii serdechno-sosudistykh narushenij u detej, bol'nykh mukoviscidozom [The role of inflammation in the development of cardiovascular disorders in children with cystic fibrosis]. Pediatriya. Vostochnaya Evropa, 2(02), 120–126. [in Russian].
Poliakov, V. V., & Senatorova, A. S. (2012). Klinicheskoe znachenie e'ndotelial'noj disfunkcii u detej s recidiviruyuschim obstruktivnym bronhitom i bronhial'noj astmoj [Clinical significance of endothelial dysfunction in children with relapsing obstructive bronchitis and bronchial asthma]. Mezhdunarodnyj medicinskij zhurnal, 2, 32–36. [in Russian].
Baldassarre, D., De Jong, A., Amato, M., Werba, J. P., Castelnuovo, S., Frigerio, B., et al. (2008). Carotid intima‐media thickness and markers of inflammation, endothelial damage and hemostasis. Annals of medicine, 40(1), 21–44. doi: 10.1080/07853890701645399.
Dinh, W., Füth, R., Nickl, W., Krahn, T., Ellinghaus, P., Scheffold, T., et al. (2009). Elevated plasma levels of TNF-alpha and interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders. Cardiovasc Diabetol, 8, 58. doi: 10.1186/1475-2840-8-58.
Kupferman J.C, Aronson Friedman L., Cox C., Flynn, J., Furth, S., Warady, B., & Mitsnefes, M. (2014). BP control and left ventricular hypertrophy regression in children with CKD. J Am Soc Nephro, 25(1), 167–174. doi: 10.1681/ASN.2012121197.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
